GSK’s 2016 Annual Report and Responsible Business Supplement

Primary tabs

GSK’s 2016 Annual Report and Responsible Business Supplement

GSK is a science-led global healthcare company. Our mission is to help people do more, feel better and live longer. We do this by researching and developing medicines, vaccines and consumer healthcare products that improve people’s lives. By growing our business and extending access to our medicines, we are ensuring long-term commercial success as well as improving people’s health, creating value for our shareholders and delivering economic benefits to society.

Review our 2016 Annual Report and Responsible Business Supplement

Learn more about GSK’s responsible business practices

Watch our new video series To Challenge. To Change.

Join the conversation on Twitter

Content from this campaign

A Graduated Approach to Intellectual Property
In 2016, we expanded our existing approach to filing and enforcing patents to ensure we balance the need to protect our intellectual property with a country’s economic maturity. We will no longer file patents for medicines in least-developed countries (LDCs) and low-income countries. In lower middle income countries (LMICs), we will apply for patents when we believe it is appropriate,...
Mar 22, 2017 11:00 AM ET
Combating Antibiotic Resistance
Resistance to antibiotics is a major public health crisis, with 700,000 people dying every year from drug resistant infections. We have 70 years of expertise in antibiotics and we’re committed to continuing our research in this area. The most advanced antibiotic in our pipeline, gepotidacin, is moving into the final phase of clinical testing and in 2016 was granted Qualified Infectious...
Mar 14, 2017 1:10 PM ET
Top Ten GSK Responsible Business Highlights in 2016
GSK is a science-led global healthcare company. Our mission is to help people do more, feel better and live longer. We do this by researching and developing medicines, vaccines and consumer healthcare products that improve people’s lives. Being commercially successful and operating responsibly allows us to improve people’s health and benefit society, as well as create value for shareholders....
Mar 14, 2017 1:10 PM ET

Pages